3P Biopharmaceuticals y Biovian se unen para formar 3PBIOVIAN, una CDMO de medicamentos biológicos líder en Europa

by 3P Biopharmaceuticals

The combined Group, named 3PBIOVIAN, will offer unparalleled end-to-end development and manufacturing services for all protein expression systems and viral vectors, both for Drug Substance and Drug Pr...

Read more

3P Biopharmaceuticals: forjando un legado de innovación y excelencia en biotecnología

by 3P Biopharmaceuticals

La empresa recibe el premio a la Mejor Trayectoria Viveros CEIN en el Congreso Internacional de Emprendimiento de Alto Impacto

Read more

3P Biopharmaceuticals lands in the United States

by 3P Biopharmaceuticals

3P Biopharmaceuticals (3P), a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing for biological drugs advances its internatio...

Read more

3P Biopharmaceuticals continues its collaboration with U.S. biotech Zhittya for the treatment of Parkinson’s disease

by 3P Biopharmaceuticals

3P Biopharmaceuticals and the American biotech company, Zhittya Genesis Medicine (Zhittya), have successfully accomplished the process transfer and GMP supply of FGF-1 candidate.

Read more

3P Biopharmaceuticals appoints Diego Bochoeyer as Director of Strategic Development and Supply Chain

by 3P Biopharmaceuticals

3P Biopharmaceuticals incorporates a new member to the executive management team by engaging Diego Bochoeyer as Director of Strategic Development and Supply Chain.

Read more

3P Biopharmaceuticals enters into alliance with Precirix to develop precision radiopharmaceuticals in oncology

by 3P Biopharmaceuticals

3P Biopharmaceuticals and Precirix NV have signed an agreement for the clinical manufacturing of a camelid single-domain antibody fragment (sdAb), the backbone of Precirix’ next product candidate to...

Read more

3P Biopharmaceuticals and Buzzard Pharmaceuticals start a collaboration to develop a new treatment to combat solid tumours

by 3P Biopharmaceuticals

3P Biopharmaceuticals and Buzzard Pharmaceuticals have entered into a partnership agreement for manufacturing of the potent IL-1 inhibitor Isunakinra, a recombinant protein for cancer indications.

Read more

3P Biopharmaceuticals y Buzzard Pharmaceuticals inician una colaboración para desarrollar un nuevo tratamiento oncológico

by 3P Biopharmaceuticals

3P se ocupará de la fabricación cGMP de Isunakinra, un medicamento contra tumores sólidos, que se encuentra en fase I/II de desarrollo en pacientes en EEUU

Read more

La esperanza de reducir las complicaciones cardiovasculares asociadas a la diálisis

by 3P Biopharmaceuticals

Las empresas biotecnológicas Invizius y 3P Biopharmaceuticals colaboran en una tecnología innovadora para los pacientes que se someten a hemodiálisis y sufren de enfermedades cardiovasculares

Read more

3P Biopharmaceuticals y SpyBiotech firman un contrato para la fabricación de vacunas

by 3P Biopharmaceuticals

3P Biopharmaceuticals, compañía biotecnológica CDMO especializada en el desarrollo de procesos y fabricación bajo normas de correcta fabricación (cGMPs) de medicamentos biológicos y productos de...

Read more

3P Biopharmaceuticals nombra a Iker Portugal como Director Financiero Corporativo

by 3P Biopharmaceuticals

Es un profesional con dilatada experiencia en el sector financiero y se une a 3P para impulsar el crecimiento de la compañía

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Horizon pone en marcha una planta punter...

by Horizon Products

Horizon ha puesto en funcionamiento una nueva planta dedicada íntegra...

Photos Stream